Literature DB >> 28791413

Knockdown of Hotair suppresses proliferation and cell cycle progression in hepatocellular carcinoma cell by downregulating CCND1 expression.

Jia-Jia Zhou1, Di Cheng1, Xiao-Yu He2, Zhe Meng1, Wen-Zhu Li1, Ru-Fu Chen1.   

Abstract

The long noncoding RNA, homeobox transcript antisense RNA (Hotair), has been demonstrated to have an important role in regulating various biological processes in various cancers, including hepatocellular carcinoma (HCC). However, the importance of Hotair in HCC proliferation and cell cycle progression remains to be elucidated. In the present study, knockdown of HOTAIR expression by RNA interference inhibited cell proliferation and induced G0/G1 cell cycle arrest in Huh7 hepatocellular carcinoma cells. In addition, the expression levels of CCND1 mRNA and its cyclin D1 protein product were reduced in Huh7 cells following knockdown of HOTAIR. Knockdown of HOTAIR reduced the expression of phosphorylated signal transducer and activator of transcription 3 (STAT3) and HOTAIR knockdown combined with STAT3 inhibition led to an additional decrease in cyclin D1 expression. The present study suggested that Hotair may have a critical role in the proliferation of HCC by regulating cell cycle, STAT3 activity and cyclin D1 expression. Therefore, Hotair may be a novel potential therapeutic target for HCC treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28791413     DOI: 10.3892/mmr.2017.7162

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

Review 1.  Long Noncoding RNAs and Human Liver Disease.

Authors:  Johanna K DiStefano; Glenn S Gerhard
Journal:  Annu Rev Pathol       Date:  2021-08-20       Impact factor: 32.350

2.  Integrated Proteomic and Transcriptomic Analysis Reveals Long Noncoding RNA HOX Transcript Antisense Intergenic RNA (HOTAIR) Promotes Hepatocellular Carcinoma Cell Proliferation by Regulating Opioid Growth Factor Receptor (OGFr).

Authors:  Ying Wu; Qian Xiong; Siting Li; Xue Yang; Feng Ge
Journal:  Mol Cell Proteomics       Date:  2017-10-27       Impact factor: 5.911

Review 3.  The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.

Authors:  Manuela Lanzafame; Gaia Bianco; Luigi M Terracciano; Charlotte K Y Ng; Salvatore Piscuoglio
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

4.  Systematic analysis of gene expression alterations and clinical outcomes of STAT3 in cancer.

Authors:  Xiangrong Cui; Xuan Jing; Qin Yi; Chunlan Long; Bin Tan; Xin Li; Xueni Chen; Yue Huang; Zhongping Xiang; Jie Tian; Jing Zhu
Journal:  Oncotarget       Date:  2017-12-14

Review 5.  Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma.

Authors:  Johanna K DiStefano
Journal:  Noncoding RNA Res       Date:  2017-12-05

Review 6.  Long Non-Coding RNA in the Pathogenesis of Cancers.

Authors:  Yujing Chi; Di Wang; Junpei Wang; Weidong Yu; Jichun Yang
Journal:  Cells       Date:  2019-09-01       Impact factor: 6.600

7.  Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Authors:  Xinrong Lin; Xiaosong Xiang; Bing Feng; Hao Zhou; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

8.  LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma.

Authors:  Xiaofeng Tang; Weichen Zhang; Yufu Ye; Hong Li; Longyu Cheng; Min Zhang; Shusen Zheng; Jun Yu
Journal:  Biomed Res Int       Date:  2020-05-09       Impact factor: 3.411

9.  Long noncoding RNA NEAT1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma through interacting with miR-384.

Authors:  Liying Zhu; Nenghong Yang; Chengcheng Li; Guoqi Liu; Wei Pan; Xing Li
Journal:  J Cell Biochem       Date:  2018-10-22       Impact factor: 4.429

Review 10.  The emerging role of the long non-coding RNA HOTAIR in breast cancer development and treatment.

Authors:  Hossein Mozdarani; Vahid Ezzatizadeh; Roghayeh Rahbar Parvaneh
Journal:  J Transl Med       Date:  2020-04-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.